CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 8-K Event Other events
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF MEDICAL OFFICER sold 684 shares at $12.98 ($8,878)
- 4 Planned sale SENIOR VICE PRESIDENT, R&D sold 4,387 shares at $11.52 ($50,538)
- 4 Planned sale SVP, GC & CORPORATE SECRETARY sold 4,387 shares at $11.52 ($50,538)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 21,125 shares at $11.52 ($243,360)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 2,191 shares at $11.52 ($25,240)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 2,191 shares at $11.52 ($25,240)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,490 shares at $11.52 ($28,685)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 514 shares at $9.51 ($4,888)
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 6,500 shares (grant or award)
Page 17 of 65 · 1,286 filings